| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Total revenue | $40K-61.3% | $104K-42.1% | $179K-58.3% | $430K |
| Practice salaries and benefits | $1.0M-49.0% | $2.0M-38.3% | $3.2M-3.1% | $3.3M |
| Other practice operating expenses | $973K-37.5% | $1.6M-29.4% | $2.2M-14.1% | $2.6M |
| Cost of product revenue | $52K-46.4% | $96K-32.5% | $143K-69.2% | $463K |
| Selling, general and administrative expenses | $2.0M-33.0% | $3.0M-16.1% | $3.6M-20.8% | $4.6M |
| Depreciation and amortization | $102K-64.0% | $283K-19.6% | $352K-57.6% | $829K |
| Impairment loss | $716K | — | $320K-88.3% | $2.7M |
| Total Operating Expenses and Costs | $4.2M-45.6% | $7.7M-22.2% | $9.9M-32.0% | $14.5M |
| Loss from operations | -$2.1M+54.8% | -$4.7M-12.7% | -$4.2M+52.1% | -$8.7M |
| Gain (loss) on extinguishment of debt | $318K+277.7% | -$179K-23.3% | -$145K | — |
| Gain (loss) on change in fair value of debt | -$618K-835.0% | $84K | — | — |
| Gain on sale of assets | $169K | — | — | — |
| Gain on change in fair value of derivative financial instruments | $9K | — | — | — |
| Amortization of original issue discounts on notes payable | -$828K+37.1% | -$1.3M-207.7% | -$428K-673.9% | -$55K |
| Gain from realization of contingent sale consideration receivable | $125K | — | $1.1M | — |
| Interest expense and other | -$216K-28.5% | -$168K-131.2% | -$73K-218.6% | -$23K |
| Total other income (expenses) | -$1.2M+19.7% | -$1.5M-370.3% | $538K-9.1% | $592K |
| Loss before provision for income taxes | -$3.3M+46.5% | -$6.1M-69.7% | -$3.6M+55.2% | -$8.1M |
| Net loss | -$3.3M+46.5% | -$6.1M-505.8% | -$1.0M+88.5% | -$8.8M |
| Basic (in Dollars per share) | -$1.16+46.8% | -$2.18 | $0.00+100.0% | -$0.04 |
| Fully diluted (in Dollars per share) | -$1.16+46.8% | -$2.18 | $0.00+100.0% | -$0.04 |
| Basic (in Shares) | 2.8M+0.7% | 2.8M-98.9% | 262.9M+8.0% | 243.4M |
| Fully diluted (in Shares) | 2.8M-99.0% | 281.5M+7.1% | 262.9M+8.0% | 243.4M |
| Patient service revenue, net | ||||
| Subscription revenue | ||||
| Product revenue | ||||
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.